Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$28.48 - $52.59 $626 - $1,156
22 New
22 $1,000
Q2 2022

Aug 11, 2022

SELL
$36.95 - $82.41 $584,290 - $1.3 Million
-15,813 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$55.7 - $145.79 $86,223 - $225,682
1,548 Added 10.85%
15,813 $1.2 Million
Q4 2021

Feb 04, 2022

BUY
$135.05 - $182.59 $618,393 - $836,079
4,579 Added 47.27%
14,265 $2.13 Million
Q3 2021

Nov 08, 2021

SELL
$145.58 - $192.14 $28,533 - $37,659
-196 Reduced 1.98%
9,686 $1.41 Million
Q2 2021

Aug 13, 2021

BUY
$134.22 - $202.37 $1.33 Million - $2 Million
9,882 New
9,882 $1.94 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.43B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.